Skip to main content
Clinical Trials/NCT00855556
NCT00855556TerminatedNot Applicable

Parkinson's Disease Genetics Database

Northwell Health1 site in 1 country16 target enrollmentStarted: February 2008Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
16
Locations
1
Primary Endpoint
the current protocol is for establishment of the registry only and not for particular analyses of its contents

Study Overview

Brief Summary

The goal of the study is to develop and organize an effort to identify genes that determine an individual's risk for developing Parkinson's disease (PD).

  1. To ascertain, study and establish a repository of DNA samples that will allow for the identification of known and yet-to-be-identified genetic markers associated with the development of PD.
  2. To create a database with clinical, genetic (HLA, genome screen) and medical history information that will facilitate the search for PD susceptibility genes.
  3. To provide a centralized DNA repository to allow for targeted studies of genetic factors contributing to the onset, heterogeneity and progression of PD.
  4. To evaluate opportunities to extend the results of research to develop methods of risk prediction, prevention and therapy for PD.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Subjects must have a diagnosis of Parkinson's Disease as determined by standard neurological criteria.
  • Patients ≥18 years of age who are able to provide informed consent
  • Patients ≥ 18 who are decisionally impaired for whom informed consent can be obtained by a legally authorized representative.

Exclusion Criteria

  • Patients without a diagnosis of Parkinson's Disease.

Outcomes

Primary Outcomes

the current protocol is for establishment of the registry only and not for particular analyses of its contents

Time Frame: 5 years

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael Pourfar

Principal Investigator

Northwell Health

Study Sites (1)

Loading locations...

Similar Trials